Two of the vaccines we have for COVID-19 have the distinction of being the first mRNA vaccines to see widespread use in ...

After a period defined by its COVID-19 vaccine, BioNTech is reasserting its presence in the oncology arena. A recent regulatory milestone and a significant upgrade from a major investment bank are ...

New research could allow health care providers to identify and treat patients at risk for rheumatoid arthritis before the ...

Researchers from the Wilmer Eye Institute, Johns Hopkins Medicine Center for Nanomedicine - which designs nanotechnology-based platforms for clinical translation across specialties - developed a ...

We depend on our government to enforce regulations that protect our health. And for nearly half of a century, Americans have relied on dietary guidance from the federal government to stay healthy.

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy cells? Research into an immune kill switch holds potential for controlling ...

A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer ...

If promising results on a skin cancer vaccine from Moderna and Merck lead to a new launch, the Covid-19 era darling's stock ...

Cancer cells have softer membranes than healthy cells. New nanoparticles exploit this physical difference to fuse selectively ...

Among patients with advanced melanoma, long-term data have shown that a personalized mRNA cancer vaccine, when combined with ...

Tuesday, the South Carolina Statehouse discussed everything from bathroom bills to ivermectin. Here's how things progressed.

Soy vey! Soybean oil is the most widely consumed cooking oil (more than 50%) in the United States and a ubiquitous ingredient ...